(Q61975178)

English

Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

ADD (English)

0 references

title

A 24-Week, Open Label, Phase IV Trial to Evaluate the Efficacy of Pioglitazone 30 mg in Patients With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy of Metformin, Sulfonylurea, and Pioglitazone 15 Mg (ADD Trial) (English)

0 references

medical condition

diabetes

0 references

sponsor

Takeda Pharmaceutical Company

0 references

start time

16 December 2013

0 references

end time

17 October 2016